Understand why cloud infrastructure is foundational to hybrid and decentralized trials and what critical trial activities it enables with reduced operational friction.
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- How To Operationalize AI-Enabled eTMF Systems Under The EU AI Act (Part 2)
- How AI-Enabled eTMF Systems Are Impacted By The EU AI Act (Part 1)
- Making AI Safety Routine: How Sites And Sponsors Can Continuously Monitor Clinical AI
- How Can AI Change Computerized System Validation?
- Digital Tools Are Failing Patients: 3 Ways Clinical Supply Can Protect Data Integrity
- Virtual Reality Endpoints Improve Measurement Of Patients' Real-World Benefit
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Patient-Centric Clinical Trials: The Power Of Choice
Patient-centric trials, advocated by the FDA, focus on offering choices to improve engagement, diversity, and data quality. Explore how expanding patient choice can benefit clinical trials.
-
Reflections From ISOQOL Conference 2024
Greta van Schoor attended the 31st Annual ISOQOL Conference, where HRQOL leaders shared insights on optimizing eCOA collection, integrating PROs, and digital health in clinical research.
-
6 Steps To Help You Choose The Right Clinical Trial Partner
The right digital partner can unlock speed, scale, and collaboration that can transform the future of your pipeline. Learn the six steps to help you choose the right partner for your trials.
-
Unify Your Data With A Centralized eClinical Platform
Despite the challenges associated with large volumes of data, maintaining quality and regulatory compliance, and enhancing patient engagement, the solutions for managing them can be simple and efficient.
-
Level Up Your Supply Chain Initiatives
Shipping and storing advanced therapeutics are complex processes, but advancements in accountability, wearables, and technology capture real-time factors critical to safety and protocol.
-
eCOA Risk Management In The Digital Age
Regulators across the globe are urging the industry to strengthen their data integrity practices. This article addresses the additional considerations that go hand in hand with the increased reliance on eSource data and the expansion of the electronic systems in clinical trials.
-
Using eConsent Data To Populate Site And Sponsor Data Systems
A top-10 pharmaceutical company was looking to reduce the amount of administrative burden on their clinical trial sites and themselves. See how we accomplished it, using eConsent.
-
Break The Contracting Bottleneck To Speed Site Activation
With the appropriate training data, AI has the capability to automate information gathering, document creation, and workflow management.
-
Digital Medicine Society Accelerates Recruitment and Results With eConsent
Find out how the Digital Medicine Society (DiMe), an interdisciplinary professional society for digital medicine, was able to deploy an eConsent module in less than two weeks to support its remote study to assess nocturnal scratching as an endpoint for patients.
-
Unified Platform Supports Rapid Implementation Of Rescue Study
Explore how these integrated solutions helped an emerging biopharma to implement a plan for study build and migration with minimal disruption to sites.
FROM THE EDITOR
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- FDA Vs. MHRA Vs. EMA: Differences In Externally Controlled Trials
- RWE Is Growing Up, And Here's Why That Matters
- The Dream Is EHR-To-EDC — eSource Is The Wake-Up Call
FEATURED PRODUCTS & SERVICES
RECENT NEWSLETTERS
- 02.19.26 -- The Clinical Tools Quietly Reshaping Trial Operations
- 02.12.26 -- How Can AI Change Computerized System Validation?
- 02.05.26 -- Digital Tools Are Failing Patients: Three Ways Clinical Supply Protects Data
- 01.29.26 -- Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders
- 01.22.26 -- The Role Of Open Source In Powering CDISC 360i